Advancements in treatment include immune checkpoint inhibitors and BRAF/MEK inhibitors, though resistance remains a challenge, with lifileucel recently approved for previously treated metastatic cases.
Jina Yun, PharmD
Advertisement
Articles by Jina Yun, PharmD
Axitinib, cabozantinib, and lenvatinib are first-line treatment options.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
CDC Adolescents, Children, & Adult Immunization Schedule: 2025 Update
3
Lower LDL-C Correlated With Lower Risk of MACE in Ischemic Stroke Survivors
4
PCV21-Unique Serotypes Most Prevalent in US Adults With Pneumococcal Disease
5
